This once-weekly GLP-1 receptor agonist is licensed in the UK for weight management in adults with obesity or overweight with weight-related comorbidities
Choose injection site: Rotate between your abdomen, thigh, or upper arm for each injection
When to contact your healthcare provider While occasional stress or worry are normal, if anxious feelings become frequent, feel overwhelming, or interfere with daily life, its important to reach out to a healthcare provider
Key Takeaways: Zepbound vs Wegovy Zepbound shows higher average weight loss: 22.5% vs 14.9% at maximum doses Zepbound (tirzepatide) acts on two hormone receptors, Wegovy (semaglutide) acts on one Both are FDA-approved specifically for chronic weight management Side effects similar but Zepbound may cause slightly more gastrointestinal issues Brand prices: Zepbound $1,069/month, Wegovy $1,349/month Compounded options: tirzepatide $349/month, semaglutide $199/month through TrimRx Insurance coverage inconsistent for both, many plans exclude weight loss medications Both require weekly self-injections using pre-filled pens Understanding Zepbound and Wegovy Both medications belong to a class called GLP-1 receptor agonists, though Zepbound technically goes beyond this single classification
